Betamethasone Dipropionate

Overview

Betamethasone Dipropionate is a potent synthetic glucocorticoid steroid with anti-inflammatory and immunosuppressant properties. It is commonly used in the treatment of skin conditions such as eczema, psoriasis, and dermatitis.

API suppliers (17)

Suppliers of Betamethasone Dipropionate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Taro Pharmaceutical Industries Ltd.Israel1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• TAPI NL BV1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• FARMABIOS SPA1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
• PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC
• QUATRUM
• HOECHST MARION ROUSSEL SA
• MAHIMA LIFE SCIENCES PRIVATE LTD

Patent & exclusivity (US)

Per the FDA Orange Book (28 approved US products), the latest listed US patent on Betamethasone Dipropionate expires 30 Aug 2030. Generic API sourcing typically opens up once these lapse.

Therapeutic areas